C042P: Clenoliximab Biosimilar, CD4 Monoclonal Antibody
Recombinant Humanized IgG4 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade clenoliximab biosimilar specifically binds to the human CD4.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by clenoliximab.BP001924-PRO-913: Recombinant Human Crystallin, Gamma D (CRYGD) Protein
Source: E. coli-derived.
Purity: > 95.0% as determined by SDS-PAGE.